Clinical Trials · NCT02963766
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 154
- Start date
- Dec 2016
- Locations
- 61 sites, 11 countries
- Primary endpoint
- Change From Baseline in Hemoglobin A1c (HbA1c) (Pooled Doses) at Week 26